MUMBAI, Aug 11 (Reuters) - Indian drugmaker Ranbaxy Laboratories (RANB.BO) said on Tuesday that it had got final approval from the U.S. Food and Drug Administration to make and sell sumatriptan succinate tablets, used to treat migraine. (Reporting by Janaki Krishnan; Editing by Himani Sarkar)
OSLO (Reuters) - There will be no "precipitous drawdown" of U.S. forces in Afghanistan and U.S. troops could still be in the country for years to come, President Barack Obama said on Thursday.
The pressure's on for oil giants looking to secure rare access to cheap Middle East reserves as Iraq gears up to auction off some of the world's largest untapped oilfields. Full Article
Recovering from a punishing global recession has forced the world's richest nations to pay dearly, prompting subdued growth prospects and delayed sighs of relief. Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
